Deutsche Bank analyst issues BUY recommendation for GM on October 9, 2026 01:07PM ET. The previous analyst recommendation was Buy.GM was trading at $82.14 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst recommendations are : 2 - Strong Buy, 32 - Buy, 13 - Hold, 4 - Sell recommendations .Historical Analyst...
Key Points - AMD turned $10,000 into over $1.2 million since 2011 - Q2 revenue for...
Key Points - Nvidia and Micron shares see a bounce as investors gain more clarity on...
Key Points - Slovakia may approve Tesla's FSD system, expanding availability in Europe - ChatGPT and...
Key Points - Michael Burry warns about Microsoft's AI spending - US labor department suspends Microsoft...
from BTIG issued a price target of $53.00 for U on 2026-10-09 11:39:22.The adjusted price target was set to $53.00.At the time of the announcement, U was trading at $45.89.The...
from Stifel Nicolaus issued a price target of $63.75 for O on 2026-10-09 11:13:54.The adjusted price target was set to $63.75.At the time of the announcement, O was trading at...
from Scotiabank issued a price target of $50.00 for VZ on 2026-10-09 10:50:06.The adjusted price target was set to $50.00.At the time of the announcement, VZ was trading at $46.35.The...
from Goldman Sachs issued a price target of $4.20 for BBD on 2026-10-09 10:16:18.The adjusted price target was set to $4.20.At the time of the announcement, BBD was trading at...
from Goldman Sachs issued a price target of $10.50 for ITUB on 2026-10-09 10:16:00.The adjusted price target was set to $10.50.At the time of the announcement, ITUB was trading at...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
In a surprising turn of events within the tech and semiconductor landscape, Micron Technology Inc. is receiving significant attention from Wall Street, with its valuation now eclipsing well-known consumer brands...
In a notable development within the tech sector, three prominent chip and software companies have issued dividend checks to their shareholders simultaneously, sparking discussion about which boards are equitably rewarding...
In a sweeping analysis of the corporate landscape heading into 2026, NYU Stern School of Business professor Aswath Damodaran, reputed as ‘The Dean of Valuation,’ has identified a fundamental divide...
Tesla Inc. (NASDAQ: TSLA) is receiving a "Buy" rating from analysts, buoyed by impressive Megapack sales and a solid customer pipeline, even as the company navigates high capital expenditure. Despite...
On a notable day in the tech sector, three leading chip and software companies distributed dividend checks to their shareholders; however, their contrasting financial narratives reflected a broader theme of...
